Phase I/II Dose-escalation Study of Lutetium-177-labeled cG250 in Patients With Advanced Renal Cancer
Clinical trial NCT00142415 · COMPLETED
Trial details
- NCT number
- NCT00142415
- Sponsor
- Ludwig Institute for Cancer Research
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-02-01
- Primary completion
- 2011-01-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.